For generations, medicine accepted that the heart, once wounded by attack, could not mend its deepest tissue — that the scar was the final word. Researchers at the University of Sydney and the Baird Institute have now challenged that long-held certainty, demonstrating for the first time in living human heart tissue that new muscle cells do emerge after a heart attack. The regeneration is modest, even fragile, but its existence reframes what recovery might one day mean for the hundreds of thousands living in the shadow of heart failure.
Human hearts can regrow muscle after attack, study shows
Heart attacks destroy up to one-third of heart cells; many survivors develop heart failure, with only ~115 transplants available annually in Australia for 144,000 patients.
The heart leaves scars, but it also generates fresh muscle tissue.
Mark
So the headline says hearts can regrow muscle after an attack. Does that mean people can recover fully from a heart attack now?
Mimi
Not yet. What the research shows is that the heart does try to regrow muscle cells after an attack. But that natural regrowth isn't strong enough to prevent the damage from heart failure. It's a starting point, not a cure.
Luke
How do we know this is actually happening in humans and not just something they're seeing in a lab dish? The source says they used tissue from living patients, but were they observing regeneration in actual hearts, or in tissue samples?
Mimi
That's a fair question. They collected tissue from bypass surgery patients and studied it in the lab. So they're not watching regeneration happen in a living heart in real time—they're studying the tissue's capacity to regenerate in a controlled setting.
Mark
Why does it matter that they used tissue from living patients instead of studying mice?
Mimi
Because what happens in a mouse heart doesn't always happen in a human heart. By studying actual human tissue, they get data that's more likely to translate into treatments that work for people.
Luke
But they haven't actually developed a treatment yet, right? They've identified some proteins that might be involved in regeneration. That's interesting, but it's still very early.
Mimi
Absolutely. They've found a potential target—these proteins—but turning that into a therapy is years away. The real value right now is overturning the old assumption that hearts can't regenerate at all.
Mark
What's the human stakes here? Why should someone care about this?
Mimi
In Australia, 144,000 people are living with heart failure. Only about 115 heart transplants happen each year. There aren't enough donor hearts. If researchers can figure out how to boost the heart's natural ability to repair itself, it could help thousands of people who currently have no good options.
Luke
So this research doesn't help anyone today, but it might help people in the future if therapies can be developed?
Mimi
That's right. It's foundational work. It changes what we think is possible, which opens the door to new research directions.
Mark
What happens next?
Mimi
The team will keep studying these tissue samples to understand exactly how the regeneration process works and which proteins are most important. Then they'll try to develop drugs or therapies that amplify that natural response.
Le Pouls
- A heart attack can obliterate up to one-third of the heart's muscle cells, and with only ~115 transplants performed annually in Australia for 144,000 patients in need, the gap between survival and recovery has long felt insurmountable.
- The discovery directly contradicts decades of clinical assumption — that adult human heart muscle, once destroyed, is permanently lost — upending the foundational logic behind how heart failure has been understood and treated.
- Using living cardiac tissue harvested during bypass surgeries at Royal Prince Alfred Hospital, researchers identified new muscle cell growth in damaged zones, offering a human-specific model that animal studies could never reliably provide.
- Several proteins linked to heart regeneration in mice have already been identified in the human samples, giving scientists molecular targets to pursue in the development of therapies that could amplify the heart's own repair response.
- The regeneration observed is real but insufficient on its own — researchers are now focused on understanding why it is so limited and whether it can be therapeutically boosted to one day replace the need for donor organs.
For generations, medicine accepted that the heart, once wounded by attack, could not mend its deepest tissue — that the scar was the final word. Researchers at the University of Sydney and the Baird Institute have now challenged that long-held certainty, demonstrating for the first time in living human heart tissue that new muscle cells do emerge after a heart attack. The regeneration is modest, even fragile, but its existence reframes what recovery might one day mean for the hundreds of thousands living in the shadow of heart failure.
For decades, cardiologists held a grim certainty: heart attack damage is permanent. The muscle cells destroyed in an attack do not return, and the scar tissue left behind defines the limits of recovery. That assumption has now been tested against living human tissue — and found incomplete.
Researchers at the University of Sydney and the Baird Institute, publishing in Circulation Research, have documented for the first time that human hearts do produce new muscle cells in the aftermath of an attack. Lead author Dr. Robert Hume was careful to temper the excitement: the regeneration is real, but it is not enough to prevent the devastating consequences of a heart attack on its own. The goal, he explained, is to develop therapies that amplify this natural process — turning a faint biological signal into a meaningful repair.
The stakes are immense. Cardiovascular disease is the world's leading cause of death, and in Australia alone accounts for nearly a quarter of all fatalities. A heart attack can destroy up to one-third of the heart's muscle cells, and many survivors go on to develop heart failure — a condition for which transplant remains the only cure. Yet with roughly 144,000 Australians living with heart failure and only about 115 transplants performed each year, the shortage is devastating.
What makes the research particularly significant is its method. Rather than relying on animal models, the team collected living cardiac tissue from bypass surgery patients at Royal Prince Alfred Hospital — samples drawn from both healthy and diseased regions of the heart. This approach, developed by Professors Paul Bannon and Sean Lal, provides a laboratory environment that more faithfully reflects human biology, where mouse findings have historically failed to translate.
Senior author Professor Sean Lal, a heart failure cardiologist, described the path ahead: identifying proteins already found in the human tissue samples that were previously linked to regeneration in mice, then using those as molecular targets to coax damaged hearts into producing more muscle. The assumption that adult human hearts cannot regenerate has shaped treatment for years. That assumption has now cracked — and with it, the possibility that thousands of patients might one day find an alternative to waiting for a heart that may never come.
For decades, cardiologists have operated under a grim certainty: when a heart attack kills muscle cells, those cells are gone for good. The scarred tissue that remains is permanent damage, a weakened pump that struggles to push blood through the body. This assumption has shaped how doctors think about recovery and prognosis. But researchers at the University of Sydney and the Baird Institute have now shown that assumption was incomplete. The human heart, they found, does attempt to rebuild itself after an attack—producing new muscle cells in the damaged zone. The finding, published in Circulation Research, doesn't erase the devastation of a heart attack, but it cracks open a door that was thought sealed shut.
Dr. Robert Hume, the study's lead author, framed the significance plainly: the heart leaves scars after an attack, yes, but it also generates fresh muscle tissue. Scientists had observed this regenerative response in mice for years. This is the first time they've documented it happening in human hearts. "Although this new discovery of regrowing muscle cells is exciting, it isn't enough to prevent the devastating effects of a heart attack," Hume explained. "Therefore, in time, we hope to develop therapies that can amplify the heart's natural ability to produce new cells and regenerate the heart after an attack." The natural repair process, in other words, is real but feeble—a starting point, not a solution.
The scale of the problem the research addresses is staggering. A single heart attack can destroy as much as one-third of the heart's muscle cells. Cardiovascular disease kills more people worldwide than any other cause. In Australia alone, it accounts for nearly a quarter of all deaths. Many patients who survive the initial attack go on to develop heart failure, a condition in which the damaged heart can no longer pump blood efficiently enough to sustain the body's organs. A heart transplant is the only cure, but the shortage is severe: Australia has roughly 144,000 people living with heart failure, yet only about 115 heart transplants are performed each year. That gap—between those who need a new heart and the organs available—defines the urgency of finding new treatments.
The research relied on an innovative approach that may prove as important as the finding itself. Researchers collected living heart tissue from patients undergoing bypass surgery at Royal Prince Alfred Hospital in Sydney. These samples came from both healthy and diseased areas of the heart, taken with patient consent during the procedure. The technique was developed by Professors Paul Bannon and Sean Lal. Because the tissue comes from living human hearts rather than animal models, it offers researchers a laboratory environment that may more closely mirror what actually occurs in patients. This matters enormously: what happens in a mouse heart doesn't always translate to human biology.
Professor Sean Lal, the study's senior author and a heart failure cardiologist at Royal Prince Alfred, described the potential path forward. "Ultimately, the goal is to use this discovery to make new heart cells that can reverse heart failure," he said. The team has already identified several proteins in the human tissue samples that previous research linked to heart regeneration in mice. Those proteins could serve as targets for future therapies—molecular handles that researchers might pull to coax a damaged human heart into producing more muscle cells. "Using living human heart tissue models in our work means that we will have more accurate and reliable data to develop new therapies for heart disease," Lal added.
The work represents a shift in how researchers think about cardiac repair. For years, the assumption that adult human hearts cannot regenerate muscle shaped the entire landscape of treatment options. Now that assumption has been tested against human tissue and found wanting. The heart does regenerate, even if only weakly. The next phase is understanding why the regeneration is so limited and whether it can be amplified. If therapies can be developed to boost this natural process, they could offer an alternative to the transplant list for thousands of patients. That remains a future goal. But the discovery provides direct evidence that the adult human heart retains at least some capacity to rebuild itself after catastrophic injury.
Citations marquantes
The heart produces new muscle cells after an attack, which opens up new possibilities for treatment, though the natural regeneration isn't yet strong enough to prevent heart failure.— Dr. Robert Hume, lead author
The goal is to use this discovery to make new heart cells that can reverse heart failure, and studying living human heart tissue will provide more accurate data to develop new therapies.— Professor Sean Lal, senior author and cardiologist
Envie de l'histoire complète ?
Lire l'original sur Science Daily ↗
Science & Space